Back to top
more

EssilorLuxottica (ESLOY)

(Delayed Data from OTC)

$109.70 USD

109.70
25,764

-0.09 (-0.08%)

Updated Apr 24, 2024 03:53 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (152 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ESLOY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for EssilorLuxottica Unsponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 2,769 2,065 3,896 9,919 5,416
Receivables 3,471 3,114 3,142 2,583 2,806
Notes Receivable 0 0 0 0 0
Inventories 2,976 2,938 2,893 2,205 2,426
Other Current Assets 1,305 986 951 968 1,392
Total Current Assets 10,521 9,104 10,882 15,672 12,040
Net Property & Equipment 5,608 5,001 4,982 3,824 4,054
Investments & Advances 88 87 108 19 20
Other Non-Current Assets 0 0 97 0 0
Deferred Charges 419 430 589 477 480
Intangibles 44,676 45,153 49,336 37,341 39,619
Deposits & Other Assets 869 861 849 427 423
Total Assets 65,504 63,807 70,309 59,763 58,893
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2,577 2,420 2,624 2,129 1,982
Current Portion Long-Term Debt 2,011 1,226 1,226 723 451
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 607 749 952 605 510
Other Current Liabilities 4,439 4,077 4,758 2,989 2,754
Total Current Liabilities 10,543 9,364 10,552 7,049 6,291
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2,322 2,504 2,903 2,156 2,393
Convertible Debt 0 0 0 0 0
Long-Term Debt 7,099 8,279 10,545 10,651 7,688
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 853 1,005 1,083 830 1,136
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 23,411 23,614 27,721 22,298 19,321
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 89 85 95 90 88
Capital Surplus 24,765 24,302 26,479 25,144 24,616
Retained Earnings 16,641 14,158 1,731 13,656 1,206
Other Equity 936 2,025 14,558 -1,195 13,738
Treasury Stock 338 379 273 230 76
Total Shareholder's Equity 42,092 40,192 42,588 37,465 39,572
Total Liabilities & Shareholder's Equity 65,504 63,807 70,309 59,763 58,893
Total Common Equity 42,092 40,192 42,588 37,465 39,572
Shares Outstanding 907.60 895.30 884.80 436.80 436.80
Book Value Per Share 46.38 44.89 48.13 85.77 90.59

Fiscal Year End for EssilorLuxottica Unsponsored ADR falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 2,769 -99,999 -98,158 -99,999
Receivables NA 3,471 NA 3,572 NA
Notes Receivable NA 0 NA NA NA
Inventories NA 2,976 NA 3,180 NA
Other Current Assets NA 1,305 NA 1,291 NA
Total Current Assets NA 10,521 NA 9,882 NA
Net Property & Equipment NA 5,608 NA 5,307 NA
Investments & Advances NA 88 NA 89 NA
Other Non-Current Assets NA 0 NA NA NA
Deferred Charges NA 419 NA 455 NA
Intangibles NA 44,676 NA 45,741 NA
Deposits & Other Assets NA 869 NA 908 NA
Total Assets NA 65,504 NA 65,669 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 NA NA NA
Accounts Payable NA 2,577 NA 2,478 NA
Current Portion Long-Term Debt NA 2,011 NA 2,190 NA
Current Portion Capital Leases NA 0 NA NA NA
Accrued Expenses NA 0 NA NA NA
Income Taxes Payable NA 607 NA 943 NA
Other Current Liabilities NA 4,439 NA 4,259 NA
Total Current Liabilities NA 10,543 NA 10,787 NA
Mortgages NA 0 NA NA NA
Deferred Taxes/Income NA 2,322 NA 2,494 NA
Convertible Debt NA 0 NA NA NA
Long-Term Debt NA 7,099 NA 7,156 NA
Non-Current Capital Leases NA 0 NA NA NA
Other Non-Current Liabilities NA NA 853 NA
Minority Interest (Liabilities) NA 0 NA NA NA
Total Liabilities NA 23,411 NA 23,837 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 NA NA NA
Common Stock (Par) NA 89 NA 89 NA
Capital Surplus NA 24,765 NA 24,916 NA
Retained Earnings NA 16,641 NA 1,484 NA
Other Equity NA 936 NA 15,750 NA
Treasury Stock NA 338 NA 406 NA
Total Shareholder's Equity NA 42,092 NA 41,833 NA
Total Liabilities & Shareholder's Equity NA 65,504 NA 65,669 NA
Total Common Equity 0 42,092 0 141,832 0
Shares Outstanding 907.60 907.60 907.20 907.20 895.30
Book Value Per Share 0.00 46.38 0.00 156.34 0.00